Suppr超能文献

评估高同型半胱氨酸血症的患病率及其对精神分裂症患者某些认知功能的影响。

Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia.

机构信息

Department of Psychiatry, Pomeranian Medical University, 26 Broniewski Street, 71-460 Szczecin, Poland.

Department of Psychiatry, Pomeranian Medical University, 26 Broniewski Street, 71-460 Szczecin, Poland.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109679. doi: 10.1016/j.pnpbp.2019.109679. Epub 2019 Jun 26.

Abstract

There is evidence that hyperhomocysteinemia may be associated with the development of schizophrenia and cognitive impairment. Therefore, the aim of this study was to analyze the relationship between cognitive functions and normal homocysteine concentrations vs. hyperhomocysteinemia in schizophrenia patients before and after supplementation with vitamins B6, B12 and folate. An 8-week prospective, non-randomized study enrolled 122 adult patients with schizophrenia (67F/55M, mean age 43.54 ± 11.94 years). Homocysteine concentrations were measured in all individuals and afterwards hyperhomocysteinemia patients (n = 42) were divided into two subgroups: treated with oral vitamins supplementation (B6 - 25 mg/d, B12 - 20 μg/d, folate - 2,5 mg/d) (n = 22) and without supplementation (n = 20). The assessment of schizophrenia symptoms severity in study group was performed using the Positive and Negative Syndrome Scale (PANSS). Cognitive functions were evaluated using the Stroop test and the Trail Making Test (TMT). We observed a higher prevalence of hyperhomocysteinemia in schizophrenia patients (34.4%) in comparison to the general population. Individuals with schizophrenia and coexisting hyperhomocysteinemia had worse performance on the Stroop and the TMT tests as well as higher PANSS scores. In these patients, supplementation with vitamins effectively decreased the homocysteine concentrations to the normal values, however there was no statistically significant improvement in the PANSS and cognitive test scores, except a significant decrease in the number of the Stroop test errors. We conclude that significant results obtained in this study show that there is a relationship between homocysteine blood concentration and schizophrenia severity. Moreover, homocysteine concentration lowering might be beneficial in schizophrenia patients with hyperhomocysteinemia in terms of cognitive functions improvement.

摘要

有证据表明,高同型半胱氨酸血症可能与精神分裂症和认知障碍的发展有关。因此,本研究旨在分析精神分裂症患者在补充维生素 B6、B12 和叶酸前后认知功能与正常同型半胱氨酸浓度与高同型半胱氨酸血症之间的关系。一项为期 8 周的前瞻性、非随机研究纳入了 122 名成年精神分裂症患者(67 名女性/55 名男性,平均年龄 43.54±11.94 岁)。所有个体均测量了同型半胱氨酸浓度,随后将高同型半胱氨酸血症患者(n=42)分为两组:口服维生素补充组(B6-25mg/d,B12-20μg/d,叶酸-2.5mg/d)(n=22)和未补充组(n=20)。使用阳性和阴性症状量表(PANSS)评估研究组中精神分裂症症状的严重程度。使用 Stroop 测试和连线测试(TMT)评估认知功能。我们观察到精神分裂症患者中高同型半胱氨酸血症的患病率较高(34.4%),高于普通人群。患有精神分裂症和并存高同型半胱氨酸血症的个体在 Stroop 和 TMT 测试中的表现更差,PANSS 评分也更高。在这些患者中,维生素补充有效地将同型半胱氨酸浓度降低到正常值,但 PANSS 和认知测试评分没有统计学上的显著改善,除了 Stroop 测试错误数显著减少。我们得出结论,本研究中的显著结果表明同型半胱氨酸血浓度与精神分裂症严重程度之间存在关系。此外,降低同型半胱氨酸浓度可能有益于伴有高同型半胱氨酸血症的精神分裂症患者认知功能的改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验